LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis.

Ching-Yi Chen,Wang-Chun Chen,Chi Hsien Huang,Yi Ping Hsiang,Chau-Chyun Sheu,Yung-Che Chen,Meng-Chih Lin,Kuo-An Chu,Cheng Hung Lee,Yu-Feng Wei

LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis.

2020

Ching-Yi Chen
Wang-Chun Chen
Chi Hsien Huang
Yi Ping Hsiang
Chau-Chyun Sheu
Yung-Che Chen
Meng-Chih Lin
Kuo-An Chu
Cheng Hung Lee
Yu-Feng Wei

Background:Long-acting muscarinic antagonist (LAMA) monotherapy is recommended for chronic obstructive pulmonary disease (COPD) patients with high risk of exacerbations. It is unclear whether long-...

Keywords:

Meta-analysis
Medicine
Lama
Intensive care medicine
COPD
pulmonary disease
Muscarinic antagonist
Internal medicine
fixed dose

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations